- Home
- PII vs ARWR Comparison
PII vs ARWR Comparison
Compare PII & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PII
- ARWR
- Stock Information
- Founded
- PII 1954
- ARWR 2003
- Country
- PII United States
- ARWR United States
- Employees
- PII N/A
- ARWR N/A
- Industry
- PII Recreational Games/Products/Toys
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- PII Consumer Discretionary
- ARWR Health Care
- Exchange
- PII Nasdaq
- ARWR Nasdaq
- Market Cap
- PII 2.6B
- ARWR 2.5B
- IPO Year
- PII 1987
- ARWR 1993
- Fundamental
- Price
- PII $57.32
- ARWR $29.72
- Analyst Decision
- PII Hold
- ARWR Strong Buy
- Analyst Count
- PII 11
- ARWR 8
- Target Price
- PII $45.30
- ARWR $47.75
- AVG Volume (30 Days)
- PII 1.2M
- ARWR 2.9M
- Earning Date
- PII 10-21-2025
- ARWR 08-07-2025
- Dividend Yield
- PII 4.68%
- ARWR N/A
- EPS Growth
- PII N/A
- ARWR N/A
- EPS
- PII N/A
- ARWR N/A
- Revenue
- PII $6,961,400,000.00
- ARWR $572,976,000.00
- Revenue This Year
- PII N/A
- ARWR $22,306.37
- Revenue Next Year
- PII $4.22
- ARWR N/A
- P/E Ratio
- PII N/A
- ARWR N/A
- Revenue Growth
- PII N/A
- ARWR 2816.20
- 52 Week Low
- PII $30.92
- ARWR $9.57
- 52 Week High
- PII $86.51
- ARWR $31.13
- Technical
- Relative Strength Index (RSI)
- PII 53.31
- ARWR 76.98
- Support Level
- PII $57.28
- ARWR $27.10
- Resistance Level
- PII $60.57
- ARWR $29.34
- Average True Range (ATR)
- PII 1.88
- ARWR 1.47
- MACD
- PII -0.17
- ARWR 0.47
- Stochastic Oscillator
- PII 46.37
- ARWR 86.89
About PII Polaris Inc.
Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.